Formats: Text / Subjects: United States / Copyright: Public domain - Digital Collections - National Library of Medicine Search Results

Start Over Formats Text ✖ Subjects United States ✖ Copyright Public domain ✖

41. Increases in reimbursement for brand-name drugs in Part D

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, June 2018
Subject(s):: Drug Costs -- trends
Drug Utilization -- trends
Insurance, Health, Reimbursement
Medicare Part D -- economics
Cost Sharing
Forecasting
Health Expenditures
Humans
United States
United States. Department of Health and Human Services.

42. Part D plans generally include drugs commonly used by dual eligibles: 2018

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, June 2018
Subject(s):: Drug Utilization
Dual MEDICAID MEDICARE Eligibility
Formularies as Topic
Medicare Part D
Insurance Benefits
Insurance, Pharmaceutical Services
Humans
United States
United States. Department of Health and Human Services.
United States.

43. Tennessee Medicaid Fraud Control Unit: 2017 onsite inspection

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, June 2018
Subject(s):: Fraud -- prevention & control
Medicaid
Federal Government
State Government
Humans
Tennessee
United States
United States. Department of Health and Human Services.

44. Entities generally met Federal Select Agent Program internal inspection requirements, but CDC could do more to improve effectiveness

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, June 2018
Subject(s):: Biohazard Release -- prevention & control
Toxins, Biological
Guideline Adherence
Laboratories
Safety
Humans
United States
United States. Department of Health and Human Services.
Centers for Disease Control and Prevention (U.S.)

45. Opioid use in Medicare Part D remains concerning

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, June 2018
Subject(s):: Analgesics, Opioid -- therapeutic use
Medicare Part D
Opioid-Related Disorders -- epidemiology
Prescription Drug Misuse
Analgesics, Opioid -- economics
Fentanyl -- adverse effects
Prescription Drug Diversion
Humans
United States
United States. Department of Health and Human Services.

46. CMS did not detect some inappropriate claims for durable medical equipment in nursing facilities

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, June 2018
Subject(s):: Durable Medical Equipment -- economics
Insurance, Health, Reimbursement
Medicare -- economics
Skilled Nursing Facilities
Home Care Services -- economics
Insurance Claim Review
Insurance Coverage
Medicaid -- economics
Nursing Homes
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)

47. Opioids in Ohio Medicaid: review of extreme use and prescribing

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, July 2018
Subject(s):: Analgesics, Opioid -- therapeutic use
Inappropriate Prescribing
Medicaid
Opioid-Related Disorders -- epidemiology
Opioid-Related Disorders -- prevention & control
Prescription Drug Misuse
Analgesics, Opioid -- administration & dosage
Humans
Ohio
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)

48. Weaknesses exist in Medicaid managed care organizations' efforts to identify and address fraud and abuse

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, July 2018
Subject(s):: Fraud -- prevention & control
Managed Care Programs
Medicaid
State Government
Humans
United States
United States. Department of Health and Human Services.

49. The MEDIC produced some positive results but more could be done to enhance its effectiveness

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, July 2018
Subject(s):: Fraud -- prevention & control
Medicaid
State Government
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)

50. Medicare Part B drug payments: impact of price substitutions based on 2016 average sales prices

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, August 2018
Subject(s):: Drug Costs
Insurance, Health, Reimbursement
Medicare Part B -- economics
Cost Savings
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)

« Previous
Next »
1
2
3
4
5
6
7
8
9
…
534
535